Pathophysiology of Asthma and COPD
Start with the big picture
Asthma is characterized by episodic, largely reversible obstruction associated with Th2-mediated eosinophilic inflammation and IgE. Mast-cell mediators can produce bronchoconstriction, while edema and mucus contribute to airway narrowing; persistent disease may remodel the airway. COPD is generally less reversible and strongly associated with smoking. Neutrophils, macrophages, and CD8⁺ T cells contribute to tissue injury, while reduced elastic recoil, airway collapse, mucus, and fibrosis restrict airflow. The diseases also differ in steroid responsiveness: asthma is generally steroid-sensitive, whereas COPD has a more limited response. This preview frames the key mechanisms and therapeutic rationales; the full lesson develops their distinctions and clinical relevance in greater detail.
What you'll learn
- Describe the Th2- and IgE-mediated inflammatory pathway in asthma.
- Identify how asthma mediators and airway changes contribute to obstruction.
- Explain the inflammatory profile and airflow-limiting mechanisms of COPD.
- Compare asthma and COPD in reversibility and steroid responsiveness.
- Relate selected disease mechanisms to therapeutic targets.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.